Javascript must be enabled to continue!
Haemodynamic gain index and heart failure incidence- Prognostic and preventive value
View through CrossRef
Abstract
Aims
Heart failure (HF) is a non-curable, life-threatening condition, characterized by impaired haemodynamic function and poor survival. This study aimed to assess the association between haemodynamic gain index (HGI) and HF incidence in men.
Methods and results
Exposure was HGI, [(HRpeak*SBPpeak) − (HRrest*SBPrest)]/(HRrest*SBPrest) measured from treadmill exercise testing in 5539 men aged 59 ± 11.5 years who were free from HF at baseline. The outcome was the incidence of HF. Cox hazard models adjusted for established risk factors were analysed for the association between HGI and HF. During 14.3 ± 6 years of follow-up, 297 cases of HF occurred (average annual incidence rate 3.7 events per 1000 person-years) and average HGI was 1.6 ± 0.7 bpm/mmHg. In a continuous model, every one unit higher in HGI was associated with a 44% [hazard ratio 0.56, 95% confidence interval (0.45–0.69), P < 0.001] lower risk of HF incidence. In a categorical model, compared with those in quartile-4 (HGI > 2.0), those in quartile-3 (HGI 1.51-2.0), quartile-2 (HGI 1.05-1.5), and quartile-1 (HGI < 1.05) exhibited 70%, 220%, and 280% higher risks for developing HF, respectively (P trend < 0.001).
Conclusion
HGI was found to be a strong predictor of HF incidence in men, supporting its prognostic value. Higher HGI was independently associated with lower risk of HF incidence, while low HGI could serve as a prognostic risk factor for HF. Integrating HGI in the screening and early detection paradigm and referring individuals with low HGI to exercise rehabilitation could potentially enhance public health and prevention strategies against HF.
Oxford University Press (OUP)
Title: Haemodynamic gain index and heart failure incidence- Prognostic and preventive value
Description:
Abstract
Aims
Heart failure (HF) is a non-curable, life-threatening condition, characterized by impaired haemodynamic function and poor survival.
This study aimed to assess the association between haemodynamic gain index (HGI) and HF incidence in men.
Methods and results
Exposure was HGI, [(HRpeak*SBPpeak) − (HRrest*SBPrest)]/(HRrest*SBPrest) measured from treadmill exercise testing in 5539 men aged 59 ± 11.
5 years who were free from HF at baseline.
The outcome was the incidence of HF.
Cox hazard models adjusted for established risk factors were analysed for the association between HGI and HF.
During 14.
3 ± 6 years of follow-up, 297 cases of HF occurred (average annual incidence rate 3.
7 events per 1000 person-years) and average HGI was 1.
6 ± 0.
7 bpm/mmHg.
In a continuous model, every one unit higher in HGI was associated with a 44% [hazard ratio 0.
56, 95% confidence interval (0.
45–0.
69), P < 0.
001] lower risk of HF incidence.
In a categorical model, compared with those in quartile-4 (HGI > 2.
0), those in quartile-3 (HGI 1.
51-2.
0), quartile-2 (HGI 1.
05-1.
5), and quartile-1 (HGI < 1.
05) exhibited 70%, 220%, and 280% higher risks for developing HF, respectively (P trend < 0.
001).
Conclusion
HGI was found to be a strong predictor of HF incidence in men, supporting its prognostic value.
Higher HGI was independently associated with lower risk of HF incidence, while low HGI could serve as a prognostic risk factor for HF.
Integrating HGI in the screening and early detection paradigm and referring individuals with low HGI to exercise rehabilitation could potentially enhance public health and prevention strategies against HF.
Related Results
What is heart failure?
What is heart failure?
Abstract
This chapter provides an overview of heart failure. The term ‘heart failure’ is usually used freely between clinicians to describe what is wrong with indivi...
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
...
Undernutrition was a prevalent clinical problem among older adult patients with heart failure in a hospital setting in Northwest Ethiopia
Undernutrition was a prevalent clinical problem among older adult patients with heart failure in a hospital setting in Northwest Ethiopia
BackgroundUndernutrition is a frequently noticed medical problem in patients with heart failure. It is caused by poor nutrient intake, malabsorption, systemic inflammation, neurohu...
Assessing survival time of heart failure patients: using Bayesian approach
Assessing survival time of heart failure patients: using Bayesian approach
AbstractHeart failure is a failure of the heart to pump blood with normal efficiency and a globally growing public health issue with a high death rate all over the world, including...
PROGNOSTIC VALUE OF CIRCULATING CATESTATIN LEVELS ON HOSPITALISED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
PROGNOSTIC VALUE OF CIRCULATING CATESTATIN LEVELS ON HOSPITALISED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Objectives
To evaluate prognostic value of circulating catestatin (CST) on hospitalised patients with acute myocardial infarction.
...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...
Treatment outcomes and associated factors among chronic ambulatory heart failure patients at Jimma Medical Center, South West Ethiopia: prospective observational study
Treatment outcomes and associated factors among chronic ambulatory heart failure patients at Jimma Medical Center, South West Ethiopia: prospective observational study
Abstract
Background
Heart failure has been one of the major causes of hospitalization across the world. Focusing on the treatment outcomes of ambula...
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
Congenital heart diseases (CHDs) are the structural abnormalities that may occur in the heart, greater veins and arteries or may include the septum between the ventricles and atria...

